Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia.

ABSTRACT:

SUBMITTER: Murray HC 

PROVIDER: S-EPMC8179851 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature